Medscape.com http://www.Medscape.com delivered in their website the following presentations as a service to pharmacists and other health professionals. It’s a great lesson for continuing education for pharmacists. Here are the details:Homepage: http://www.medscape.com/
http://www.medscape.com/viewprogram/4722?src=hp30.cme
Managing Resistant Nosocomial Infections: Bringing New Treatment Options to Light CME/CE
David L. Paterson, MD, PhD; Robert A. Weinstein, MD; Susan J. Rehm, MD
Disclosures
Release Date: December 29, 2005; Valid for credit through December 29, 2006
Credits Available
Pharmacists - up to 2.0 ACPE continuing education credits for pharmacists (0.2 CEUs)
This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Managing Resistant Nosocomial Infections: Bringing New Treatment Options to Light" symposium held at the San Francisco Marriott in San Francisco, CA on October 6, 2005.
This activity is offered in two formats. Please choose one of the versions:
Slides and Audio Version
(A multimedia presentation with synchronized audio, slides and transcript.)
--OR--
Slides with transcript:
1. The Evolution of Antimicrobial Resistance in the Hospital Setting: Unveiling the Patterns
by David L. Paterson, MD, PhD
Epidemiology of Antimicrobial Resistance
Community-Acquired Infection: Will It Change Empiric Prescribing Patterns?
Gram-Negative Bacilli: Resistance Patterns
Community-Acquired Extended-Spectrum Beta-Lactamases
Carbapenemase-Producing Klebsiella
Treating Hospital-Acquired Panresistance
2. Infection Control Measures: Meeting the Challenges of Compliance and Containment
by Robert A. Weinstein, MD
Nosocomial Pathogens and Reaching Safety Goals
Hand Hygiene and Other Preventions
Isolation, Contact Precautions, and the Environment
Antibiotic Utilization and Effectiveness
Device-Related Infections
Improving Host Defenses
3. What's on the Horizon? Advances in the Treatment of Infections Due to Resistant Healthcare-Associated Pathogens
by Susan J. Rehm, MD
Increasing Antimicrobial Resistance and Few New Drugs
Current Antimicrobials: Activity and Resistance
New Antimicrobials in the Pipeline: A Cephalosporin, a Carbapenem, a Quinolone
New Antimicrobials in the Pipeline: Glycopeptides
A New Antibiotic in a New Class of Antimicrobials: Tigecycline, a Glycylcycline
Tigecycline Clinical Trial Results
Take this program with you!
Download this Web Conference as an MP3 and load it onto your iPod or other portable audio player for audio CME on-the-go.
MP3 Audio file David L. Paterson, MD, PhD
MP3 Audio file Robert A. Weinstein, MD
MP3 Audio file Susan J. Rehm, MD
(Right-click and select "Save Target As…" to download)
Print slides & transcripts
These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities.
Direct questions or comments to: CME@webmd.net.
